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ABSTRACT
RNA that can specifically bind to double-stranded
DNA is of interest because it might be used as
a means to regulate transcription of the target
genes. To explore possible interactions between
RNA and duplex DNA, we selected for RNA
aptamers that can bind to the long terminal
repeats (LTRs) of human immunodeficiency virus
type 1 DNA. The selected aptamers were classified
into four major groups based on the consensus
sequences, which were found to locate in the
non-stem regions of the predicted RNA secondary
structures, consistent with roles in target binding.
Analysis of the aptamer consensus sequences sug-
gested that the conserved segments could form
duplexes via Watson–Crick base-pairing with
preferred sequences in one strand of the DNA,
assuming the aptamer invaded the duplex. The
aptamer binding sites on the LTR were experimen-
tally determined to be located preferentially at these
sites near the termini of double-stranded target
DNA, despite selection schemes that were
designed to minimize preferences for termini. The
results presented here show that aptamer RNAs
can be selected in vitro that strand-invade at
preferred DNA duplex sequences to form stable
complexes.
INTRODUCTION
Oligonucleotides that can bind speciﬁcally to the
double-stranded (ds) DNA are of major interest due to
their possible use as molecular tools for gene manipula-
tions. Previous studies have shown that single-stranded
(ss) DNA, RNA or synthetic nucleic acids [e.g. peptide
nucleic acid (PNA)] can speciﬁcally recognize and bind
to the dsDNA targets through various interactions such
as triple helix formation or strand invasion (1–7). As a
result of binding, these dsDNA-directed oligonucleotides
can prevent other trans-acting factors such as transcrip-
tion factors from interacting with the dsDNA targets,
leading to suppression/activation of transcription or in-
hibition of DNA replication (8–11). In addition, they
can be modiﬁed to contain DNA-reactive agents or
nucleic-acid motifs capable of recruiting other proteins,
which then lead to modulation of the processes involving
the target genes, e.g. expression, repair, recombination or
mutagenesis (12–16). These properties make them very
appealing as artiﬁcial gene modulators with therapeutic
potential (17–20).
Among the nucleic acids, RNA is particularly interest-
ing for such roles because it can be expressed from recom-
binant DNA constructs inside cells, making it suitable for
intracellular use such as in gene therapy. RNA has previ-
ously been shown to speciﬁcally recognize and interact
with dsDNA. One of the binding interactions is through
a triple helix formation, in which the ssRNA inserts itself
into the major groove of DNA and forms a triple-helical
complex (21,22). This interaction has also been shown to
affect the transcription of the target DNA (23–25).
However, there are some limitations for this interaction.
First, triple helix formation between dsDNA and ssRNA
requires a long stretch of polypurine/polypyrimidine tract
on the duplex DNA as a binding site for the RNA third
strand. This would exclude a number of genes as potential
targets because they might not contain such sequences.
Moreover, some of the reported RNA–DNA triplex for-
mation needs acidic conditions for a stable binding
(21,26), restricting the use of ssRNA-directed triplexes
in vivo.
To ﬁnd RNA that can recognize and bind to duplex
DNA targets at approximately physiological pH and
ionic strength in a sequence-speciﬁc manner, in vitro
aptamer selection, or SELEX (Systematic Evolution
of Ligands by EXponential enrichment), techniques
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oligonucleotides capable of binding speciﬁcally to a par-
ticular ligand from a large pool (>10
15 sequences) of
random-sequence ss oligonucleotides (27–30). In this
study, the 30 long terminal repeat (LTR) of human im-
munodeﬁciency virus type 1 (HIV-1) was used as a
target because this region is important for virus gene ex-
pression (31) and the LTR-binding RNA ligands
(aptamers) thus generated might be useful for the suppres-
sion of HIV proliferation. Using this approach, it was
expected that novel ssRNA–dsDNA interactions might
be discovered and studied, leading to a better understand-
ing that would allow a rational design of artiﬁcial
RNA-based gene regulators.
MATERIALS AND METHODS
Materials
DNA oligonucleotides were synthesized by the University
of Michigan DNA core facility. Streptavidin–agarose
beads were from GIBCO BRL. Taq DNA polymerase,
T7 RNA polymerase and Sequenase were prepared in
house (32–34). Superscript II was from Invitrogen.
Generation of the random sequence RNA library
The RNA library was generated as previously described
(35,36). Brieﬂy, the library template was synthesized from
0.2mmol of ss deoxyoligonucleotides containing 40-nt
randomized central sequence ﬂanked by deﬁned
primer-binding sites with the sequence of 50-AGTAATA
CGACTCACTATAGGGAGTCGACCGACCAGAA
(N40) TATGTGCGTCTACATCTAGACTCAT-30. The
ssDNA was converted into dsDNA by a primer extension
reaction using Taq DNA polymerase with 0.2mmol of the
30 N40 primer (50-ATGAGTCTAGATGTAGACGCAC
ATA-30). The dsDNAs, which contains a T7 RNA poly-
merase promoter at the 50 end, were used as templates of
an in vitro transcription reaction to generate an RNA
library; the resulting RNA sequences were 50-GGGAGU
CGACCGACCAGAA [N40] UAUGUGCGUCUACAU
CUAGACUCAU-30 (84nt) with a calculated library com-
plexity of  7 10
16 different RNA sequences. The in vitro
transcription reaction was then extracted twice with
phenol/chloroform, precipitated with ethanol, and resus-
pended in 20ml of 50mM Tris pH 8.0, 200mM NaCl. The
RNAs were separated from leftover nucleotides and
primers using size exclusion chromatography on
Sephadex G-100.
Preparation of dsDNA targets
The DNA fragments of the 30 LTR were generated from
a plasmid containing HIV-1 genome, pBenn7 (37,38),
kindly provided by Dr Gary J. Nabel. The LTR-325 and
LTR-408bp (Figure 1) corresponding to the positions
9261–9585 and 9219–9626 of the 30 LTR (accession
number AF324493), respectively, were generated by PCR
ampliﬁcation with the following primers; 50 LTR-325bp
50-GGAGAGAACACCAGCTTG-30,3 0 LTR-325bp
50-GTTCCCTAGTTAGCCAGAG-30,5 0 LTR-408bp
50-CTAGTACCAGTTGAGCCAGATAA-30 30 LTR-
408bp 50-TGAAGCACTCAAGGCAAGCTT-30. The
biotinylated fragments were generated using the primers
containing biotin at the 50 ends through non-cleavable
linkers (BioTEG). The PCR products were gel-isolated
in 8% polyacrylamide gel and electroeluted. The puriﬁed
LTRs were extracted with phenol/chloroform, precipitated
in ethanol and resuspended in the binding buffer (50mM
HEPES pH 7.4, 10mM MgCl2 and 100mM NaCl).
In vitro selection of duplex DNA-binding RNA ligands
The RNA ligands or aptamers capable of binding to the
LTRs were selected from the RNA library for a total of
10 rounds (Figure 1) of binding, ampliﬁcation of bound
Figure 1. The dsDNA targets and the selection schemes used for the
aptamer selection. (A) The intended DNA target is a 325-bp dsDNA
segment of the HIV-1 30 LTR, which spans the U3 and R regions
(LTR-325bp), corresponding to the positions +1 to + 325. The other
target is a 408-bp DNA fragment (LTR-408bp), which has about 40bp
of the LTR sequences (shaded boxes) extending from both ends
of LTR-325bp and corresponds to the positions  42 to +366.
(B) Diagram of the selection schemes used to obtain the RNA
speciﬁc to dsDNA.
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biotinylated LTRs were immobilized on streptavidin–
agarose beads and used as the targets for selection.
RNA (0.5–40 nmol or 1–25mM) was incubated with the
biotinylated LTR-bound streptavidin beads containing
0.025–0.4 nmol or 0.05–0.2mM of LTRs in the binding
buffer (50mM HEPES pH 7.4, 10mM MgCl2 and
100mM NaCl). The binding reaction was done in a
column at room temperature for 1h. The beads were
then washed and the RNAs were eluted from the beads
with elution buffer (8M urea, 5mM EDTA). The eluted
RNAs were ampliﬁed by reverse transcription polymerase
chain reaction (RT–PCR) and in vitro transcription reac-
tions to generate RNAs for the next round of selection as
previously described (35,36). Subtraction steps with
agarose beads were included, starting from Round 2, to
remove RNAs having afﬁnity toward the bead matrices
instead of the DNA targets. In the last three rounds of
selection (Rounds 8–10), the LTR-binding aptamers were
enriched using electrophoretic mobility shift. Brieﬂy, the
radiolabeled RNA (5–10pmol) was incubated with 5mg
(20pmol) of unmodiﬁed LTRs in the binding buffer at
room temperature for 1h. Non-speciﬁc DNA fragments
(50mg) prepared from salmon sperm DNA cut with AluI
were also added to the binding reaction as competitor
DNAs to remove RNAs that might have non-speciﬁc
afﬁnity toward DNAs. The samples were then loaded
into a non-denaturing 6% polyacrylamide in the binding
buffer, and run at 60V for 4h. The shifted band corres-
ponding to the DNA : RNA complexes were excised. The
RNAs were then eluted with 8M urea and undergone RT–
PCR and in vitro transcription reactions. The PCR
products from the ﬁnal round were cloned into pGEM-T
vector (Promega). Individual aptamers were characterized
for the afﬁnity to the LTRs by electrophoretic mobility
shift assays and sequenced by dideoxy chain termination
methods. Their sequences were analyzed and grouped ac-
cording to the consensus sequences. The secondary struc-
tures were predicted using a secondary-structure prediction
software, RNAstructure version 4.4 (39,40) and they were
drawn using an RNA secondary structure visualization
program, RnaViz 1.0 (41).
Electrophoretic mobility shift assay
The radiolabeled aptamer (5000 cpm or 0.1pmol) was
incubated with 1mg (5pmol) of LTR-325bp, 1.25mg
(5pmol) of LTR-408bp or 5mg of non-speciﬁc DNA frag-
ments prepared by combining various plasmids (e.g.
pUC9, pBR322) and digested with MspI. The reaction
was done in the binding buffer (5ml total volume) and
incubated for 1h at room temperature. The sample was
then loaded into a non-denaturing 6% polyacrylamide in
the binding buffer and run at 60V for 4h. The gels were
dried and radioactive bands were visualized using a
PhosphorImager (Molecular Dynamics). The assay was
also used to test the binding of aptamers to various
LTR fragments, i.e. the 50 fragments of 250 and 292bp,
and the 30 fragments of 116 and 75bp, generated from
PvuII-cleaved LTR-325 and LTR-408bp, respectively.
To study the afﬁnity of the aptamer toward the LTR
targets, the radiolabeled aptamer (20nM) was incubated
with different concentrations of either LTR-325 or
LTR-408bp (0–10mM) and the electrophoretic mobility
shift assays were done as described above. The apparent
dissociation constant was then determined as described by
Soukup et al. (22).
Linker-scanning analysis of the aptamer binding sites
When Dnase I and S1 nuclease footprinting of the RNA–
DNA interactions failed to give deﬁnitive results, we used
substitution mutants in the LTR to deﬁne the binding
sites. Various LTR-325bp fragments containing 18bp
of the NdeI–XhoI–SalI linker sequences sequentially
replacing the wild-type sequence from positions +1 to
+325 were generated by PCR ampliﬁcation. Most of the
fragments were ampliﬁed from the plasmids containing
the linker-scanning mutants of HIV-1 LTR (42). Some
linker-scanning LTR fragments, i.e. those containing the
linker sequences at+16 to+33,+302 to+320 and+321 to
+325, were generated by PCR-directed mutagenesis. The
PCR fragments were puriﬁed using polyacrylamide gel
electrophoresis and the electrophoretic mobility shift
assays of the aptamers and the linker-scanning LTR frag-
ments were done as described above. It is noted that the
linker-scanning mutants used here were derived from the
HIV-1 strain HBX2 (42), the LTR sequence of which is
different from that of the HIV-1 strain used in this selec-
tion at the following positions: +42A!G, +54T!G,
+109G!A and +236G!C (Figure 1A). We found no
signiﬁcant difference in the aptamer binding to the ‘wild
type’ LTR fragments derived from these two strains.
RESULTS
In vitro selection of the aptamers speciﬁc to the dsDNAs
containing the HIV-1 30 LTR sequence
The aim of this study is to evaluate the possibility of
generating RNA aptamers capable of speciﬁc recognition
of dsDNA. In this study, the 30 LTR of HIV-1 was chosen
as the target. It is 325 -bp long spanning the regions of U3
and R regions (Figure 1A), thus called LTR-325bp. The
in vitro selection, or SELEX (28), technique was used to
obtain RNA that can bind speciﬁcally to LTR-325bp. The
binding was done in the binding buffer containing 50mM
HEPES pH 7.4, 10mm MgCl2 and 100mM NaCl. In our
preliminary selections, the aptamers had a tendency to
bind to the ends of dsDNA, probably due to transient
strand separation near the DNA ends and DNA : RNA
duplex formation. To avoid this problem and to promote
the binding of RNA toward the internal region of dsDNA,
several selection schemes were used (Figure 1B). The ﬁrst
strategy (protocol A) used alternating dsDNA targets,
i.e. LTR-325 and LTR-408bp. LTR-408bp has extra se-
quences of  40bp extending from both 50 and 30 ends of
the LTR-325bp. These two fragment targets were
alternated during the ﬁrst seven rounds of column selec-
tion in order to avoid enrichment of the undesired
aptamers with preferential binding to the dsDNA ends
of LTR-325bp. The subsequent three rounds of
8308 Nucleic Acids Research, 2010,Vol.38, No. 22electrophoretic mobility shift selections used either the
short LTR-325bp or long LTR-408bp DNA fragments.
The resulting aptamer pools were designated as aptamers
AS and AL, respectively. In contrast, the second strategy
(protocol B) used only LTR-325bp as the target through-
out the column selection. Then LTR-325bp was used
again as the target during the electrophoretic mobility
shift selections to generate the aptamer BS or the target
was shifted to LTR-408bp to generate the aptamer BL in
order to enrich the aptamers that favor the binding to the
internal region, not to the ends, of the target DNAs.
After a total of 10 rounds of selection, the binding of the
aptamers to the target dsDNA fragments was assessed
using electrophoretic mobility shift assays (Figure 2).
The starting pool of RNA from the library showed no
detectable afﬁnity to any dsDNA targets, i.e. LTR-325
and LTR-408bp, or non-speciﬁc dsDNA fragments
derived from AluI-cut salmon sperm DNA. In contrast,
the aptamer pools showed speciﬁc binding to the LTR
fragments used in the selection, but not to the non-speciﬁc
dsDNA. Interestingly, the aptamers bound the two LTR
fragments differently, depending on the selection schemes.
For example, the aptamers AL, which were generated
from the scheme that strongly favored the binding to
both LTR-325 and LTR-408bp, bound comparatively
well to both fragments, whereas the BS aptamers, which
was selected against LTR-325bp for the entire selection,
showed stronger binding to LTR-325bp, compared with
LTR-408bp.
Cloning and characterizing the dsDNA-binding aptamers
Individual aptamers from different selection schemes were
cloned and their sequences and binding afﬁnities to the
LTR fragments were determined. Based on the consensus
sequences, the aptamers could be classiﬁed into four major
groups, i.e. Groups 1–4, and an unclassiﬁed group, in
which the individual aptamers do not have any shared
sequence (Figure 3A–D). In the predicted secondary struc-
tures of most aptamer groups, the consensus sequences
were found to be in the non-base-pairing regions, suggest-
ing that the ‘ss’ regions have probable roles in speciﬁc
recognition of targets. The number of aptamer clones
screened, frequencies and binding characteristics of the
aptamers from various groups are summarized in Table 1.
It is interesting to note that the aptamers within each
group share not only the consensus sequences, but also the
binding characteristics. Most of the unclassiﬁed aptamers
showed weak or no binding to the LTR targets in the
mobility shift assays. The aptamers from Groups 1 and
2 aptamers bound strongly to LTR-325bp but weakly, if
not at all, to LTR-408bp, whereas the Group-3 aptamers
bound almost exclusively to LTR-408bp. From their
binding characteristics, the Groups 1–3 aptamers seem
to bind to the ends of the target dsDNA. In contrast,
the Group-4 aptamers bound comparatively well to both
LTR-325 and LTR-408bp. This gave us an initial impres-
sion that their binding site probably resided within the
internal region of the dsDNA target, which is the
desired property for the study (however, this proved not
to be the case based on the results of the subsequent ex-
periments below).
We, therefore, focused on the properties of the Group 4
members. To assess the binding strengths of the aptamers
toward the LTR fragments, the apparent dissociation con-
stants (Kd) of the aptamers were determined by electro-
phoretic mobility shift assays. The apparent Kd values of a
representative aptamer from Group 4 (clone AL66) to
LTR-325 and LTR-408bp were 1.2 and 0.3mM, respect-
ively (Figure 3E). The binding of Group-1 and -2
aptamers to LTR-325bp in this assay (data not shown)
displayed strengths in the same approximate range
(0.1–2mM).
Determination of the aptamer binding sites on the LTR
targets
To approximate the binding sites of the various aptamer
classes, LTR-325 and LTR-408bp were cleaved with a
blunt-end restriction enzyme, PvuII, to generate the 50
fragments of 250 and 292bp and the 30 fragments of 116
and 75bp, respectively (Figure 4). These fragments were
used as the targets of the representative aptamers from
each group in electrophoretic mobility shift assays. Both
Group-1 and -2 aptamers were previously shown to bind
strongly to the LTR-325bp. In this experiment, the
binding sites of the aptamers from Groups 1 and 2 were
located to the 75-bp 30 fragment and the 250-bp 50
fragment of LTR-325bp, respectively. In contrast, the
Group-4 aptamers, which bind to both LTRs, surprisingly
Figure 2. Electrophoretic mobility shift assays of the round 10 aptamers pools AS, AL, BS and BL to the double-stranded LTR targets compared
with that of the RNA library. Lanes a–d correspond to RNA only, RNA + LTR-325bp, RNA + LTR-408bp and RNA + non-speciﬁc dsDNA
fragments, respectively. The arrows indicates the position of free RNA, and the complexes between RNA and either LTR-325bp or LTR-408bp.
Nucleic Acids Research, 2010,Vol.38, No. 22 8309do not seem to bind at the same binding site on LTR-325
and LTR-408bp. The representative aptamer bound most
strongly to the 75-bp 30 fragment of LTR-325 and to the
292-bp 50 fragment of LTR-408bp. These two fragments
are not overlapping, suggesting that the Group-4
aptamers have at least two separate binding sites for the
different LTR targets. The Group-4 aptamer binding sites
could be deduced from this experiment; the ﬁrst one is
from positions  42 to  1 and the other is from+251 to
+325 (Figure 1), respectively.
To reﬁne the above ﬁndings, a detailed mapping of the
aptamer binding sites on the LTR targets was performed.
Figure 3. The sequences, predicted secondary structures (39,40), and binding characteristics of the aptamers. The aptamers are classiﬁed into four
major groups, i.e. group 1–4, based on the consensus sequences [(A)–(D), respectively]. Only the randomized sequence of each aptamer are shown
with the consensus sequence underlined. The consensus sequences (shown in boxes) are frequently located within the non-base-pairing regions of the
predicted secondary structures. Each aptamer group also displays different binding afﬁnity to the different double-stranded LTR targets as shown in
electrophoretic mobility shift assays (Lanes a–c correspond to RNA only, RNA+LTR-325 and RNA+LTR-408bp, respectively). (E) The apparent
dissociation constants (Kd) of a representative aptamer from group 4 (clone AL66) were determined by electrophoretic mobility shift assays; the plot
shows % binding as a mean ± S.E. The Kd to LTR-325 and LTR-408bp are 1.2 and 0.3mM, respectively.
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printing’ of DNA cleavage accessibility did not give de-
ﬁnitive results, so identiﬁcation of the binding sites was
performed through characterization of the effects of
‘linker scanning’ mutations. PCR fragments of the
LTR-325bp mutants, which have the NdeI–XhoI–SalI
linker sequences (18bp) sequentially replacing the wild-
type sequence from positions +1 to+325 were generated
from previously characterized clones (22). The mutants
are named ‘n/m’ where n and m are the 50- and 30-most
positions, respectively, where the wild-type sequence is
replaced with the linker sequence. These mutants were
used as the targets for the aptamers in electrophoretic
mobility shifts assays. The binding sites of the aptamers
could then be deduced from the loss of aptamer binding to
the mutants containing the putative binding sites. As
shown in Figure 5, the representative aptamer from
Group 1 lost its binding to the LTR mutants 302/319
and 320/325, suggesting that the binding site of Group-1
aptamers are located at the 30 end of LTR-325bp,
corresponding to the positions +302 to +325. In
contrast, that of the Group-2 aptamer was located at the
50 end of LTR-325bp, corresponding to the positions+1
to +13. For the Group-4 aptamers, which appeared to
have two separate binding sites on LTR-325 and
LTR-408bp, its binding site on LTR-325bp were
Figure 5. Determination of the aptamer binding sites on LTR-325bp
using linker-scanning LTR mutants. A set of the double-stranded
LTR-325bp mutants that have the NdeI–XhoI–SalI linker sequences
(18bp) sequentially replacing the wild-type sequence from positions+1
to +325 was used as the targets for the aptamers in electrophoretic
mobility shifts assays; the numbers in each lane indicate the 50-most
and 30-most positions, respectively, where the wild-type sequence is
replaced with the linker sequence. Asterisks indicate the linker-scanning
LTR mutants that show very little or no binding with the aptamers.
Table 1. The frequencies and binding characteristics of the aptamers derived from different selection schemes in electrophoretic mobility shift
assays
Selection
schemes
No. of
aptamers
screened
Group 1
bind to
LTR-325bp
(%)
Group 2
bind to
LTR-325bp
(%)
Group 3
bind to
LTR-408bp
(%)
Group 4
bind to
both LTRs
(%)
Unclassiﬁed (no consensus sequences)
bind to
LTR-325bp
(%)
bind to
LTR-408bp
(%)
bind to
both LTRs
(%)
No or weak
binding
(%)
AS 15 27 – – 13 20 – – 40
AL 54 2 – 4 22 4 2 7 59
BS 15 33 27 – – 13 – – 27
BL 15 13 – – – 13 – – 74
Figure 4. Determination of the aptamer binding sites using
PvuII-cleaved LTR fragments. The double-stranded LTR-325 and
LTR-408bp were cleaved with a restriction enzyme, PvuII, into
smaller fragments, which were used as targets in electrophoretic
mobility shift assays; Lane a corresponds to RNA only, Lanes b and
c to RNA + either the 50 or 30 fragment of LTR-408bp (292- and
116-bp fragments, respectively), Lanes d and e correspond to RNA +
either the 50 or 30 fragment of LTR-325bp (250- and 75-bp fragments,
respectively). The arrows indicate the complexes between the aptamer
and the cleaved DNA fragments.
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+302 to +319. The results from this experiment are in
agreement with those of the experiment using the
PvuII-cleaved LTR fragments for the binding site
determination.
Analysis of the aptamer/target binding interactions
Because the consensus sequences of most aptamers are
located within the non-base-pairing regions of the pre-
dicted secondary structures (Figure 3A–D), it was
hypothesized that the aptamers bind to the LTR targets
through the consensus sequences. Therefore, the possible
interactions between the LTR sequences at the putative
binding sites (from the above experiments) and the con-
sensus sequences were speculated. For the Group-1
aptamers, which bind strongly to LTR-325bp, their con-
sensus sequence (50-CUAGGGAAC-30) could potentially
form a perfect duplex with the bottom strand of
LTR-325bp at positions +317 to +325 using canonical
base-pairing (Figure 6). This is consistent with the
binding site determined using the linker-scanning experi-
ment, which is in the region of positions+302 to+325. A
similar ﬁnding is observed with the Group-3 aptamers,
which bind only to LTR-408bp. All 10 nucleotides of
the Group-3 consensus sequence (50-AUCAUGGUC
A-30) could potentially form perfect canonical base-
pairing with the top strand at the 50 end of LTR-408bp,
spanning the positions  41 to  32. For the Group-4
aptamers, which have two separate binding sites
on LTR-325 and LTR-408bp, their consensus sequence
(50–UGGCNNAACUGGG-30) is predicted to form com-
plementary base-pairing with both LTR targets in spite of
some degree of mismatches and the use of non-canonical
base-pairing. One binding site (Site 1) is at the 50 end of
LTR-408bp at positions  36 to  25 (top strand), while
the other site (Site 2) is at the 30 end of LTR-325bp at
positions +310 to +321 (bottom strand); this is in agree-
ment with the results from the previous experiments
(Figures 4 and 5), which deﬁned the Group-4 aptamer
binding sites on LTR-408 and LTR-325bp at positions
 42 to  1 and+302 to+319, respectively. However, for
the Group-2 aptamers, which were shown to bind to the
50 end of LTR-325bp at positions +1 to +13 (Figures 4
and 5), the base complementarity between the consensus
sequence (50-GUGGGGUGGUGGCUG-30) and the
putative target sequence is not as obvious as those of the
Figure 6. The putative binding sites of various aptamer groups on LTR-325 and LTR-408bp. The representative aptamer and consensus sequence
from each group are aligned with the target sequence(s) on the LTRs. Solid and dashed lines indicate the canonical and non-canonical base-pairings,
respectively.
8312 Nucleic Acids Research, 2010,Vol.38, No. 22other aptamer groups (Figure 6). Their consensus
sequence (15-nt long) is quite G rich (%G  67), and
only 11 nucleotides (out of 15) are predicted to form
base-pairing with the putative target sequence, i.e. the
top strand at the 50 end of LTR-325bp, from positions
+6 to+19; the binding thereof was conﬁrmed by electro-
phoretic mobility shift assays (data not shown).
Non-canonical base-pairing predictions (4 out of 11) are
also more frequently observed in this group.
DISCUSSION
RNA that can speciﬁcally bind to dsDNA can be very
useful as a means to regulate transcription of the target
DNA. However, some of previously described RNA–
dsDNA interactions still have some limitations (21,26).
Therefore, in this study, we aimed to explore novel inter-
actions between RNA and dsDNA at approximately
neutral pH and modest ionic strength. The 30 LTR of
HIV-1 was chosen as the target in this study. This target
DNA does not contain a long stretch of polypurine/
polypyrimidine tract; the longest stretch is only 10bp,
which is unlikely to favor a stable triplex formation
(21,22). Thus, novel interactions other than triplex could
be expected.
SELEX was used to discover RNA aptamers capable of
binding to the dsDNA fragments of the 30 LTR. Four
major groups of the LTR-speciﬁc aptamers were
isolated, i.e. Groups 1–4. Interestingly, these aptamers
tend to bind to the termini of the duplex DNA,
probably through the invasion of the DNA strands
followed by base-pairing formation between the target
and aptamer consensus sequences, resulting in RNA :
DNA duplexes. This end invasion is also supported
from the ﬁndings that the RNA aptamers, particularly
from Groups 1 and 2, no longer bind to LTR-408bp,
although their target sequences are present within
this longer LTR fragment, but not at the termini (Figure
3A–B). Based on this approach, we found that binding of
aptamers to the ends of the target DNAs seems to be a
major mode of interactions as the previous data from two
independent aptamer selections using only LTR-325bp as
a target also produced similar results; the end-binding
aptamers with the consensus sequences exactly the same
as those of Groups 1 and 2 were isolated. Because of this,
different schemes were devised to minimize the
end-binding RNAs by using alternating short and long
LTR fragments that have different sequences at the
dsDNA ends as targets (Figure 1B). However, the RNA
aptamers obtained still bind to the ends of both target
DNAs. In addition to the Group-1 and -2 aptamers
isolated before, the selection schemes led to the isolation
of the Group-4 aptamers, which can bind to the termini of
both LTRs. They seem to do this by adopting the use of
non-canonical base-pairing to form duplexes with the
target sequences with some degree of tolerance to base
mismatches. This is in contrast to the aptamers that
bind exclusively to only one target (either LTR-325 or
LTR-408bp) such as those from Groups 1 and 3; only
canonical base-paring is used and there is no mismatch
between the target and aptamer consensus sequences. Of
the end-binding aptamers, those from Group 2 are quite
interesting. Unlike the other end binders, complementarity
between the aptamer consensus sequence of Group 2 and
the target DNA sequence is not continuous and seems to
have more non-canonical base-pairing and mismatches.
Due to the G-rich nature of these Group-2 aptamers,
it might be possible that the aptamers might adopt
non-standard structures such as a quadruplex or
G-quartet to mediate the binding with the target DNA.
Nevertheless, the actual nature of the binding interaction
is still not clear and might be worth further investigation.
There are several explanations as to why the RNA
aptamers prefer to bind to the end of DNA instead of
the sequence in the internal region. Because the
aptamers recognize the dsDNA through base-pairing
with the target sequences, separation of DNA strands is
required and the base pairs at the DNA termini separate
more readily than the base pairs in the internal region of
DNA (43–45); this makes the DNA termini the preferred
sites for strand invasion by the aptamers. In addition, if
the binding occurs within the DNA target, two helix
boundaries will form at the edges of RNA–DNA
strand-invasion complexes and the energetic cost of such
boundary formation is unacceptably high (46). Therefore,
the aptamer binding to the sequences at the DNA ends is
more favorable because no new helix boundary needs to
be formed. Recently, there is a study of oligonucleotides
with similar binding characteristics to the LTR-binding
aptamers, i.e. short PNAs with mixed-base composition
(46). These mixed-base PNAs invade the DNA strands
of the targets at the termini to form PNA : DNA
duplexes. However, the end invasion is efﬁcient only at
the very end of the DNA termini; no binding is
observed if the PNA-binding site is placed just two nu-
cleotides away from the end and no mismatch is tolerated.
On the other hand, the aptamers, particularly from Group
4, can bind to the LTRs even though their binding sites are
situated up to 4bp away from the ends and they can
tolerate some mismatches. Furthermore, the aptamers
can bind to the dsDNA targets at physiological pH and
ionic strength, while the mixed-base PNAs do so only at
low salt conditions; higher salt (>20mM) inhibits the
binding. It might be possible that other motifs in the
aptamer structures besides the consensus sequence might
help stabilize the binding as well.
Although the dsDNA-binding aptamers isolated in this
study can bind to the target dsDNA by strand invasion
and formation of RNA : DNA duplexes, their binding
strengths are somewhat moderate (apparent Kd in a low
micromolar range). Thus, they might or might not be ef-
fective in vivo as therapeutic tools. Moreover, their poten-
tial aptamer targets (i.e. the sequences at the dsDNA ends)
might not be common inside cells except in some in-
stances, e.g. during DNA replication, where a number
of DNA ends are generated, or during transcription,
where the DNA strands are transiently separated in a
transcription bubble favoring strand invasion; such con-
ditions would favor the aptamer binding to dsDNA.
In addition, the presence of topoisomerases or supercoiled
structures of DNA in vivo could reduce the resulting DNA
Nucleic Acids Research, 2010,Vol.38, No. 22 8313strain generated during the strand separation and might
theoretically favor the aptamer binding to the internal
DNA sequences. These could make the aptamers more
useful as gene-directed therapeutic agents or molecular
tools for genetic analysis or gene manipulations.
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